We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > late-stage

News List

Takeda ditches late-stage Ninlaro trial pharmatimes
June 11, 2019
Takeda has announced the premature ending of its Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory systemic light-chain (AL) amyloidosis, due to the study not meeting the first of two primary endpoints.
Evolution Research Acquires Finger Lakes Clinical Research contractpharma
April 02, 2019
Specializes in pediatric and adult central nervous system trials for major national and international pharmaceutical firms
AbbVie halts late-stage TAHOE study of Rova-T in small-cell lung cancer firstwordpharma
December 06, 2018
AbbVie on Wednesday announced that it was stopping enrolment of the Phase III TAHOE study assessing rovalpituzumab tesirine, also known as Rova-T, as a second-line treatment for patients with advanced small-cell lung cancer.